Holen Sie sich die Stockscreener-App
108.67
0.01%
0.0878
Schlusskurs vom Vortag:
$108.58
Offen:
$108.71
24-Stunden-Volumen:
29,149
Relative Volume:
0.07
Marktkapitalisierung:
$907.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.46%
1M Leistung:
-0.04%
6M Leistung:
+21.97%
1J Leistung:
+15.53%
1-Tages-Spanne:
$107.92
$108.71
1-Wochen-Bereich:
$107.18
$111.70
52-Wochen-Spanne:
$77.67
$112.58
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Firmenname
Vaneck Pharmaceutical Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare PPH vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
108.59 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
338.63 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
686.16 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
689.27 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
275.69 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
611.02 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Aktie (PPH) Neueste Nachrichten
Eli Lilly Dominance: The Impact of a Single Stock on Pharma ETF Performance - Intellectia AI
Citigroup Inc. Grows Stake in VanEck Pharmaceutical ETF $PPH - Defense World
Avalon Trust Co Has $24.89 Million Position in VanEck Pharmaceutical ETF $PPH - Defense World
Merck Inks AI Drug Discovery Deal With Mayo Clinic To Revolutionize Drug Discovery - Sahm
VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion - AOL.com
PPH Should I Buy - Intellectia AI
PPH Technical Analysis & Stock Price Forecast - Intellectia AI
Palmetto Grain Brokerage - Palmetto Grain Brokerage
How AI Is Reshaping Drug Discovery and Healthcare Investing - VanEck
How AI Is Reshaping Drug Discovery And Healthcare Investing - Seeking Alpha
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - sharewise.com
VanEck Pharmaceutical ETF $PPH Shares Sold by Adamsbrown Wealth Consultants LLC - Defense World
VanEck pharmaceutical fund bets big on weight-loss drug market approaching $150 billion - MSN
Economist Warns Trump's Full Drug Tariff Will Burden Americans, Not Foreign Companies - intellectia.ai
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Significant Increase in Short Interest - Defense World
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Large Volume Increase Following Dividend Announcement - Defense World
Osaic Holdings Inc. Has $1.95 Million Stake in VanEck Pharmaceutical ETF $PPH - Defense World
VanEck ETF TrustVanEck Pharmaceutical ETF announces Quarterly dividend, payable on December 31, 2025 - MarketScreener
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Benzinga
Pharma's $370B Bet on America: The ETF Plays for 2026 - The Globe and Mail
Why PPH Keeps Working When Single Themes Break (NASDAQ:PPH) - Seeking Alpha
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal - sharewise.com
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.6069 - MSN
Fisher Asset Management LLC Sells 1,263,699 Shares of VanEck Pharmaceutical ETF $PPH - Defense World
AI in Pharma and Biotech: Market Trends 2025 and Beyond - VanEck
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight - Benzinga
Bank of Montreal Can Sells 4,190 Shares of VanEck Pharmaceutical ETF $PPH - Defense World
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs - Benzinga
VanEck Pharmaceutical ETF (Nasdaq:PPH) Stock Quote - FinancialContent
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - TradingView
Avalon Trust Co Lowers Position in VanEck Pharmaceutical ETF $PPH - Defense World
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' - Benzinga
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? - TradingView
Finanzdaten der Vaneck Pharmaceutical Etf-Aktie (PPH)
Es liegen keine Finanzdaten für Vaneck Pharmaceutical Etf (PPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):